The biotech investor’s bible
An investment consultant, formerly a journalist who reported on the emergence of recombinant DNA technology, discusses the maturing biotech sector from new investment strategy and scientific/ technological perspectives. Appendices include a breakdown of 185 major biotech companies by market cap and...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Boek |
| Taal: | Undetermined |
| Gepubliceerd in: |
New York
John Wiley & Sons
2001
|
| Onderwerpen: | |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
| Thư viện lưu trữ: | Trung tâm Học liệu Trường Đại học Cần Thơ |
|---|
| Samenvatting: | An investment consultant, formerly a journalist who reported on the emergence of recombinant DNA technology, discusses the maturing biotech sector from new investment strategy and scientific/ technological perspectives. Appendices include a breakdown of 185 major biotech companies by market cap and tier, resources, and a glossary of biotech terms. |
|---|